invest data long-term growth
mix result strong us perform report solid
result ebit adj one-off acquisit cost yoy non-
gaap ep flat vs higher cs estim
benefit lower tax rate takeaway strong us mask
gener growth respect manag note
continu take share product categori row devic
impact lower upgrad sale france/japan gross margin
prior year benefit manufacturing/procur
effici product-mix chang higher contribut saa
perform core sleep busi us strong
recent invest build saa platform matrixcar
propel health acquisit verili jv led manag
guid higher sg a/sal d/sale net interest cost oei loss
factor new guidanc decreas ep estim
forecast period
row devic cycl strong upgrad sale
benefit chang cpap reimburs schedul franc
japan group revenu respect exist cpap
user upgrad cloud-connect devic growth remain strong
new patient set-up patient upgrad sale forecast row
devic yoy remain flat
maintain outperform decreas dcf target price
trade cs revis forward ep ahead
two-year averag premium
industri ex fin increas invest data platform
remain upbeat potenti use data improv qualiti
care patient home set drive complianc increas
penetr rate within sleep copd market
catalysts/risk integr recent acquisit competitor product
launch chang cpap reimburs tariff row
valuat metric
chang previou ep
price month
total return forecast perspect
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
price jan rate outperform target price analyst gretel janu
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
 asx close
spot exchang rate
net interest
net profit tax
sale divis
gross margin consist
matrixcar expect ep accret
propel expect ep dilut per quarter
equiti loss expect quarter due verili jv
net interest per quarter due acquisit
revenu yoy cs forecast
continu grow devic market share healthcar provid physician
choos script
revenu yoy despit cycl stronger comp line cs
continu gain share mask despit competitor launch new
product initi feedback posit also launch
provid addit choic custom
saa benefit acquisit organ growth mid-high singl
saa revenu yoy
saa revenu aid healthcar first acquisit month matrixcar
contribut well increment contribut tuck-in acquisit
design drive increas growth core brightre softwar busi
organ growth base brightre busi mid-high singl digit
row devic cycl benefit france/japan
weak due cycl upgrad franc japan reimburs
manag expect see weak franc japan revenu growth
next quarter expect return market growth devic within franc
japan market growth within rest geographi
continu gain traction mask categori
gross margin improv higher proport saa revenu
gross profit cs forecast gross margin
vs prior quarter
matrixcar accret gross margin remaind benefit due
manufactur effici favour product mix partial off-set typic asp
sg cc exclud acquisit sg would cc
sg percentag revenu improv line cs estim
 vs pcp revenu
non-gaap ep beat cse due lower tax rate vs
cse lower tax rate due one-off benefit employe
share base payment transact quarter
incorpor number chang forecast follow result
revenu decreas row gener growth assum upgrad
france/japan lower row gener sale growth
assum growth pick growth rate thereaft
gross margin increas gross margin overtim continu
increas greater revenu contribut saa divis
sg increas sg cost cost line guidanc
sale sale respect
interest cost factor higher interest cost due higher debt level
oei factor verili jv estim loss make next
currenc updat cs in-hous currenc forecast relev fx exposur
aggreg decreas earn estim averag
current trade cs revis forward price-to-earnings repres
premium rel industri ex-financi two-year averag
respect
figur long-term multipl
figur trade premium market
pe multipl rel xji ex-financi
chart bloomberg professionaltm servic credit suiss estim
depreci asset
figur us group revenu
revenu composit segment
figur sale yoy row gener
revenu segment us mn
figur us gener driven revenu
revenu segment us mn
figur us mask growth remain strong
revenu growth segment cc
figur gross margin yoy
figur yoy
cost revenu
chart compani data credit suiss estim
figur gener account sale figur forecast shift mask
mix sale
chart compani data credit suiss estim
new total return forecast perspect chart help visual credit suiss consensu view compani return within
context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock volatil
stock volatil shade area show one standard deviat rang base past month volatil statist
term make number brave assumpt probabl share price end insid rang month
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around mean
repres rang estim lowest highest estim aid visualis number import factor rang
analyst estim credit suiss estim stock sit rel consensu share price rel consensu
mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang use
consensu target price consensu dividend forecast month forward
compani mention price
